Feno-TG 145mg Tablet contains Fenofibrate, a lipid-modifying agent used primarily to treat hypercholesterolemia and hypertriglyceridemia. Fenofibrate works by activating peroxisome proliferator-activated receptor alpha (PPARα), which increases the oxidation of fatty acids and reduces the production of triglycerides and very low-density lipoprotein (VLDL) cholesterol in the liver. This action helps lower elevated levels of total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides, while increasing high-density lipoprotein (HDL) cholesterol, thereby reducing the risk of cardiovascular disease. Feno-TG 145mg is typically prescribed for patients who have not achieved adequate lipid control through diet and lifestyle changes alone. It is important to take this medication with food to enhance absorption and minimize gastrointestinal discomfort. Patients should adhere to their prescribed dosage and continue regular monitoring of lipid levels and liver function tests during therapy. Common side effects may include gastrointestinal disturbances, muscle pain, and elevated liver enzymes, and any unusual symptoms should be reported to a healthcare provider promptly. Feno-TG 145mg is contraindicated in patients with severe liver or kidney impairment, gallbladder disease, or hypersensitivity to fenofibrate. This medication should be used under medical supervision as part of a comprehensive cardiovascular risk management plan.